Thiazolidinediones with thyroid hormone receptor agonistic activity

Chem Pharm Bull (Tokyo). 1999 Sep;47(9):1348-50. doi: 10.1248/cpb.47.1348.

Abstract

Several thiazolidinedione derivatives (3-7) were designed and synthesized as candidate thyromimetic drugs. Among them, the dihydrogenated compounds, such as 5-2-[[4-(3-tert-butyl-4-hydroxyphenyl)oxy-3,5-diiodophenyl] ethyl]-2,4-thiazolidinedione (6b) and its 3-isopropyl analog (7b), exhibited potent thyroid hormone receptor alpha 1 (TR alpha 1) activation activity.

MeSH terms

  • Animals
  • COS Cells
  • Humans
  • Luciferases / genetics
  • Luciferases / metabolism
  • Nuclear Proteins / metabolism
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Retinoic Acid / drug effects
  • Receptors, Thyroid Hormone / antagonists & inhibitors*
  • Structure-Activity Relationship
  • Thiazoles / chemical synthesis*
  • Thiazoles / pharmacology
  • Transcription Factors / metabolism

Substances

  • Nuclear Proteins
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Retinoic Acid
  • Receptors, Thyroid Hormone
  • Thiazoles
  • Transcription Factors
  • Luciferases